Thanks NR,
With 10 million between the lawyers and Aruda hopefully that $0 cost basis supply is getting close to being exhausted. That would only leave Aspire who will have a much higher cost basis.
I think it would be reasonable to expect him to be much more selective in selling the remaining 6 million when he receives those.
LEGEND OF ABBREVIATIONS
B = Brilacidin, the antibiotic
K = Kevetrin, the oncology drug
P = Prurisol, the psoriasis drug
SAE = Serious Adverse Event
IND = Investigational New Drug